Clinical Trial Update: The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude [EARLY_Phase 1]

View source ↗

Summary

An early-stage clinical trial is evaluating whether acetazolamide can reduce inflammation and innate immune activation at high altitude. The goal is to mitigate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mountain Sickness

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of California, Riverside | Conditions: Hypoxemia, Acute Mountain Sickness (AMS) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING